Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash flows from investing activities | ||
| Purchases of investment securities | (52,589) | (86,548) |
| Proceeds from maturities of investment securities | 45,000 | 94,490 |
| Purchases of property and equipment | — | (72) |
| Net cash (used in) provided by investing activities | (7,589) | 7,870 |
| Cash flows from financing activities | ||
| Proceeds from the issuance of common stock in at-the-market offering, net of issuance costs | 19,907 | — |
| Proceeds from the exercise of stock options | 27 | 23 |
Item 1. Financial Statements.
FAQ
- What is Design Therapeutics, Inc.'s capex?
- Design Therapeutics, Inc. (DSGN) reported capex of $0 in Q1 2026.
- How has Design Therapeutics, Inc.'s capex changed year-over-year?
- Design Therapeutics, Inc.'s capex decreased by 100.0% year-over-year, from $72K to $0.
- What is the long-term trend for Design Therapeutics, Inc.'s capex?
- Over 3 years (2021 to 2025), Design Therapeutics, Inc.'s capex has grown at a -49.9% compound annual growth rate (CAGR), from $1.54M to $193K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Design Therapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude